← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1993Last known activity
Jan 10, 2023
Timeline
1970s
- Sep 25, 1974
Deutsche Krebshilfe e.V.— Founded
Drugs by trial phase (69 distinct, 32 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenoma
- Adenoma, Villous
- Aggression
- Carcinoma
- Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Gallbladder Neoplasms
- Glioblastoma
- Head and Neck Neoplasms
- Hepatic Veno-Occlusive Disease
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rectal Neoplasms
- Sarcoma
- Stomach Neoplasms
- Urinary Bladder Neoplasms
Recent trials (32)
- NCT06019130CollaboratorPhase 2Jan 10, 2023
- NCT05212012CollaboratorPhase 1/Phase 2Feb 17, 2022
- NCT04808245CollaboratorPhase 1Dec 6, 2021
- NCT04447352CollaboratorPhase 3Dec 17, 2020
- NCT04469699CollaboratorPhase 2Nov 30, 2020
- NCT04495088CollaboratorPhase 3Sep 30, 2020
- NCT04375605CollaboratorPhase 3May 31, 2020
- NCT04043494CollaboratorPhase 3Aug 1, 2019
- NCT03643276CollaboratorPhase 3Jul 15, 2018
- NCT03206671CollaboratorPhase 3Aug 3, 2017
- NCT03158389CollaboratorPhase 1/Phase 2Jul 1, 2017
- NCT02902237CollaboratorPhase 1May 8, 2017
- NCT03117816CollaboratorPhase 2Apr 26, 2017
- NCT02684708CollaboratorPhase 3Oct 1, 2015
- NCT01704586CollaboratorN/AMay 1, 2015
Details
- Founded
- Bonn, DE Sep 25, 1974
- Last known activity
- Jan 10, 2023